Company Overview and News
Share prices of oil marketing and aviation companies rallied 4-6 percent intraday on Thursday following the sharp correction in crude oil prices in the international markets.
IOC INDIGO BPCL 500547 BRQPY 532617 HINDPETRO JETAIRWAYS 530965 500104 539448
Reliance Industries (RIL), Aegis Logistics, GAIL and Gujarat Gas rallied 2-4 percent intraday on Tuesday as the bidding for the ninth round of City Gas Distribution Scheme closes later today.
IOC 500325 BPCL 500547 RELIANCE 539336 AEGISLOG 530965 532514 IGL GUJGAS BRQPY RIGD GAILY 500003 HINDPETRO GAILF 500104 RLNIY
LONDON (July 6): Asian spot liquefied natural gas (LNG) prices declined for a third week on producers from Australia to Nigeria boosting spot supply, strong European LNG inventories and Pakistan's cancellation of a six-cargo tender.
CQP BPCL 500547 BRQPY LNG
Mumbai: State-owned fuel marketers are pushing back against a regulatory suggestion to allow Reliance Industries Ltd (RIL) to use their pipelines to sell jet fuel at the Mumbai airport.
IOC 500325 BPCL 500547 BRQPY RELIANCE RIGD HINDPETRO 530965 500104 RLNIY
LONDON, July 7 — Asian spot liquefied natural gas (LNG) prices declined for a third week on producers from Australia to Nigeria boosting spot supply, strong European LNG inventories and Pakistan’s cancellation of a six-cargo tender.
CQP BPCL 500547 BRQPY LNG
SINGAPORE (Reuters) - Sellers of U.S. sour crude oil have cut their offers for Asian buyers on concern that demand may fall as China threatens to impose tariffs on oil from the United States and Middle East supply may rise after major producers agreed to increase output, multiple trade sources said on Wednesday.
BPCL 500547 BRQPY
SINGAPORE, July 4 (Reuters) - Sellers of U.S. sour crude oil have cut their offers for Asian buyers on concern that demand may fall as China threatens to impose tariffs on oil from the United States and Middle East supply may rise after major producers agreed to increase output, multiple trade sources said on Wednesday.
BPCL 500547 BRQPY
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
IOC 5017 BPCL 500547 BRQPY 530965 5020
The Nifty and the Sensex are trading on a positive note this Tuesday afternoon after a flat morning session with the Nifty up 35 points at 10,797 and the Sensex is trading higher by 120 points at 35,591.
GRASIM 500408 500325 BRTQY JISLJALEQS ICLQY UCLQY 532480 BJJQY 500570 BRITANNIA CLNDY RLNIY ASHOKLEY SBAZ 500219 GRSJY BPCL TVSMOTOR UNITDSPR ALBK APOLLOTYRE AYRQY 530005 532822 517334 ULTRACEMCO AKLD 532432 BAJFINANCE BATAINDIA BRQPY UQNTY 500300 534809 HINDPETRO PCJEWELLER 500104 COALINDIA AKLS ABBOTINDIA 500825 500547 PQRTY RELIANCE PUNJLLOYD 512573 532538 533155 BHRQY NAUKRI JUBLFOOD 533278 532777 532343 MOZTY 532461 RIGD JBLWY 500477 INDIACEM BHARTIARTL TATAMOTORS 500034 570004 UBNC HINDALCO AVANTI 500877 UCLQF PETRONET 532522 532454 HNDNF GRSXY PNJZY 532693 MOTHERSUMI JISLDVREQS IDEA TATAELXSI PNB 500488 500043 500440 TTM
New Delhi : Abu Dhabi National Oil Company (Adnoc) on Monday signed an initial pact to take a stake in the planned $44-billion refinery in Maharashtra, joining Saudi Aramco which is looking at the project as a vehicle to enter India’s entire energy “value chain” including fuel retailing.
IOC BPCL 500547 BRQPY HINDPETRO 530965 500104
Benchmark indices ended at day's low with Nifty slipped below 10,800 and Sensex fell over 200 points as selling pressure seen in major banking, pharma and metal names.
IOC 500325 BPCL 500547 RELIANCE 530965 521070 BRQPY RIGD ALOKTEXT HINDPETRO 500104 RLNIY
2018-07-13 - Asif
Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...
2018-07-09 - Asif
Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...
2018-07-06 - Asif
Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...